A detailed history of Aqr Capital Management LLC transactions in Surmodics Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 14,980 shares of SRDX stock, worth $570,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,980
Previous 20,228 25.94%
Holding current value
$570,588
Previous $850,000 31.76%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$38.47 - $42.24 $201,890 - $221,675
-5,248 Reduced 25.94%
14,980 $580,000
Q2 2024

Aug 14, 2024

SELL
$25.39 - $42.1 $586,102 - $971,836
-23,084 Reduced 53.3%
20,228 $850,000
Q1 2024

May 15, 2024

BUY
$27.44 - $35.56 $478,306 - $619,846
17,431 Added 67.35%
43,312 $1.27 Million
Q4 2023

Feb 14, 2024

BUY
$28.47 - $38.49 $736,832 - $996,159
25,881 New
25,881 $940,000
Q2 2022

Aug 15, 2022

SELL
$33.25 - $45.11 $171,503 - $232,677
-5,158 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$40.68 - $49.72 $597,670 - $730,486
-14,692 Reduced 74.02%
5,158 $234,000
Q4 2021

Feb 14, 2022

SELL
$43.21 - $57.6 $96,099 - $128,102
-2,224 Reduced 10.08%
19,850 $956,000
Q3 2021

Nov 15, 2021

BUY
$52.8 - $60.32 $34,372 - $39,268
651 Added 3.04%
22,074 $1.23 Million
Q2 2021

Aug 16, 2021

BUY
$51.29 - $59.15 $72,011 - $83,046
1,404 Added 7.01%
21,423 $1.16 Million
Q1 2021

May 17, 2021

BUY
$42.18 - $56.07 $13,455 - $17,886
319 Added 1.62%
20,019 $1.12 Million
Q4 2020

Feb 16, 2021

BUY
$35.18 - $43.52 $165,170 - $204,326
4,695 Added 31.29%
19,700 $857,000
Q3 2020

Nov 16, 2020

BUY
$37.98 - $48.72 $243,755 - $312,684
6,418 Added 74.74%
15,005 $584,000
Q2 2020

Aug 17, 2020

BUY
$31.07 - $44.74 $17,740 - $25,546
571 Added 7.12%
8,587 $371,000
Q1 2020

May 15, 2020

SELL
$22.46 - $42.24 $683,031 - $1.28 Million
-30,411 Reduced 79.14%
8,016 $267,000
Q4 2019

Feb 14, 2020

SELL
$39.01 - $47.51 $4.1 Million - $5 Million
-105,186 Reduced 73.24%
38,427 $1.59 Million
Q3 2019

Nov 14, 2019

SELL
$38.66 - $47.41 $976,164 - $1.2 Million
-25,250 Reduced 14.95%
143,613 $6.57 Million
Q2 2019

Aug 14, 2019

SELL
$38.23 - $47.43 $1.17 Million - $1.45 Million
-30,631 Reduced 15.35%
168,863 $7.29 Million
Q1 2019

May 14, 2019

SELL
$41.26 - $58.35 $507,332 - $717,471
-12,296 Reduced 5.81%
199,494 $8.67 Million
Q4 2018

Feb 14, 2019

BUY
$44.93 - $73.38 $2.52 Million - $4.12 Million
56,095 Added 36.03%
211,790 $10 Million
Q3 2018

Nov 15, 2018

BUY
$56.85 - $80.35 $8.07 Million - $11.4 Million
141,881 Added 1027.08%
155,695 $11.6 Million
Q2 2018

Aug 14, 2018

BUY
$35.85 - $57.05 $51,695 - $82,266
1,442 Added 11.66%
13,814 $763,000
Q1 2018

May 15, 2018

SELL
$27.0 - $38.5 $391,257 - $557,903
-14,491 Reduced 53.94%
12,372 $471,000
Q4 2017

Feb 14, 2018

SELL
$28.0 - $33.2 $1.68 Million - $1.99 Million
-59,827 Reduced 69.01%
26,863 $752,000
Q3 2017

Nov 14, 2017

BUY
$24.5 - $31.1 $2.12 Million - $2.7 Million
86,690
86,690 $2.69 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $533M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.